FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression
PR Newswire - Food and Drug Administration (FDA) has approved SEROQUEL(R) (quetiapine fumarate) for the treatment of patients with Bipolar I disorder is characterized by one or more manic or mixed episodes, often with episodes of major depression, whereas
Source: sev.prnewswire.com
NIH Spends Millions to Study Alternative Therapy
NPR News - Patients who received both types of treatment felt 40 percent less pain than those who received only standard treatment John's Wort is another popular herbal supplement, but NCCAM found that it's useless for treating major depression of moderate
Source: www.npr.org
Diet and Genes
MSNBC - in the first place. Last month researchers at Duke University discovered that some people have a variant gene which reduces the production of serotonin by 80 percent—making them both susceptible to major depression and resistant to treatment with
Source: www.msnbc.msn.com
Remission Possible, But Hard to Sustain
Psychiatric News - Because the report connects acute treatment outcomes to longer-term prognosis in a well-characterized patient population of more than 3,600 patients, it may end up being one of the most important ever published on the treatment of major depression. The
Source: pn.psychiatryonline.org
Depressed Senior Citizens in Primary Care Benefit Most From Team
Senior Journal - Lesser depressions often lead to major depression but goes undiagnosed in elderly April 4, 2006 – Elderly patients with any The study helps answer a major question in the treatment of depression — when to discontinue medication. Read
Source: www.seniorjournal.com
Click here for more information about manic depression symptom manic depression symptom
<< Home